7682
S. K. Singh et al. / Tetrahedron Letters 45 (2004) 7679–7682
10. Tables of atomic coordinates, anisotropic thermal para-
meters and bond lengths etc. may be obtained free of
charge from The Director, CCDC, 12 Union Road,
Cambridge CB2 1EZ, UK, on quoting the deposition
number CCDC 242156, the names of the authors and the
journal citation (fax: +44 1223 336 033; e-mail: deposit@
Single crystals suitable for X-ray diffraction were grown
from a mixture of MeOH and EtOAc. A half mole
equivalent of EtOAc is present in the crystal lattice. The
compound crystallized as colourless needles in monoclinic
space group Pna21 with cell dimensions a = 7.736 (2),
b = 18.365 (4), c = 20.742 (5), and V = 2946.9 (11) con-
taining four molecules in the unit cell. The intensity data
were collected on a Rigaku AFC-7S single crystal diffrac-
of 1,5-diarylpyrazoles 4–12 and a table of elemental
analysis are available.
References and notes
1. (a) Almansa, C.; Gomez, L. A.; Cavalcanti, F. L.; de
Arriba, A. F.; Garcia-Rafanell, J.; Form, J. J. Med. Chem.
1997, 40, 547–558; (b) Daidone, G.; Maggio, B.; Plescia, S.;
Raffa, D.; Musiu, C.; Milia, C.; Perra, G.; Marongiu, M. E.
Eur. J. Med. Chem. 1998, 33, 375–382; (c) Finn, J.; Mattia,
K.; Morytko, M.; Ram, S.; Yang, Y.; Wu, X.; Mak, E.;
Gallant, P.; Keith, D. Bioorg. Med. Chem. Lett. 2003, 13,
2231–2234; (d) Nargund, L. V. G.; Hariprasad, V.; Reddy,
G. R. N. J. Pharm. Sci. 1992, 81, 892–894; (e) Zhihua, S.;
Guan, J.; Michael, F. P.; Kathy, M.; Michael, W. P.;
William, M. V.; Monica, S.; Michele, S.; Dave, R. M.;
Dennis, C. Bioorg. Med. Chem. Lett. 2000, 10, 601–604.
2. (a) Kenzi, M.; Ho, S. K.; Yoshihisa, K. J. Heterocycl.
Chem. 1998, 35, 489–497; (b) Kenzi, M.; Ho, S. K.;
Yoshihisa, K. J. Heterocycl. Chem. 1999, 36, 321–332.
3. Li, J.; DeMello, K. M. L.; Cheng, H.; Sakya, S. M.;
Bronk, B. S.; Rafka, R. J.; Jaynes, B. H.; Ziegler, C. B.;
Kilroy, C.; Mann, D. W.; Nimz, E. L.; Lynch, M. P.;
Haven, M. L.; Kolosko, N. L.; Minich, M. L.; Li, C.;
Dutra, J. K.; Rast, B.; Crosson, R. M.; Morton, B. J.;
Kirk, G. W.; Callaghan, K. M.; Koss, D. A.; Shavnya, A.;
Lund, L. A.; Seibel, S. B.; Petras, C. F.; Silvia, A. Bioorg.
Med. Chem. Lett. 2004, 14, 95–98.
4. Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J.
S.; Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.;
Malecha, J. W.; Miyashiro, J. M.; Rogers, R. S.; Rogier,
D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn,
J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.;
Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P.
C. J. Med. Chem. 1997, 40, 1347–1365, and references
cited therein.
5. (a) Elguero, J. In Comprehensive Heterocyclic Chemistry;
Katrizky, A. R., Rees, C. W., Eds.; Pergamon: Oxford,
1984; Vol. 5, pp 273–291; (b) Wiley, R. H.; Hexaner, P. E.
Org. Synth. Coll. 1963, IV, 351–353.
˚
tometer using MoKa (k = 0.7107A). The structure was
solved by direct methods, and was refined using least
squares procedures and the TEXSAN software. The present
R factors are: R (Rw) = 0.117 (0.133, with 2808 reflec-
tions). Both, the O-propanoyl and the lattice ethyl acetate
are disordered.
11. (a) Murray, W.; Wachter, M.; Barton, D.; Forero-Kelly,
Y. Synthesis 1991, 18–20; (b) Wachter, M. P.; Ferro, M. P.
EP-248594, 1987; Chem. Abstr. 1988, 108, 186735v.
12. Representative procedure: 1,5-di(4-methoxyphenyl)-3-n-
propyl-1H-pyrazole
6a.
4-Methoxyphenylhydrazine
hydrochloride (2.0g, 11.46mmol) was suspended in abso-
lute ethanol (30mL) under Ar and to the agitated reaction
mixture was slowly added TEA (2.89g, 28.65mmol) at
room temperature, which achieved a pH of ꢀ11.0. After
stirring for a further 15min, an ethanolic solution of 1-(4-
methoxyphenyl)-1,3-hexanedione 3 (2.39g, 10.88mmol)
was added, and the mixture was heated at 50–60°C for 4–
5h. The solvent was removed and the residue was stirred
with ice-cold water. After acidification with 6N HCl, the
solution was extracted with EtOAc and the combined
organic layers were washed with brine and water. The
dried organic layer after solvent evaporation left behind a
dark residue, which on column chromatographic purifica-
tion over 230–400mesh silica gel using ethyl acetate–
petroleum ether (15:85) and repeated trituration with
petroleum ether afforded the desired product (2.62g, 78%)
as an off-white low melting solid. Alternatively, the
mixture of 4-methoxyphenylhydrazine (2.0g, 14.49mmol)
and 1-(4-methoxyphenyl)-1,3-hexanedione (3.02g, 13.76
mmol), dissolved in absolute ethanol (30mL) which
attained a pH of ꢀ5, on heating under Ar at 50–60°C
for 4–5h, followed by a similar work-up and purification,
afforded the same product in almost the same yield. IR
6. Kost, A. N.; Grandberg, I. I. In Advanced Heterocyclic
Chemistry; Katrizky, A. R., Boulton, A. J., Eds.; Aca-
demic: NewYork, 1966; Vol. 6, pp 358–374.
7. (a) Singh, S. K.; Reddy, P. G.; Rao, K. S.; Lohray, B. B.;
Misra, P.; Rajjak, S. A.; Rao, Y. K.; Venkateswarlu, A.
Bioorg. Med. Chem. Lett. 2004, 14, 499–504; (b) Singh, S.
K.; Saibaba, V.; Shivaramakrishna, S.; Krishnamraju, A.;
Rajjak, S. A.; Rao, C. S.; Akhila, V.; Rao, Y. K. Bioorg.
Med. Chem. Lett. 2004, 14, 1683–1688.
(neat) 2959, 1612, 1516, 1453, 1248cmÀ1 1H NMR
.
8. (a) Wang, X.; Tan, J.; Grozinger, K.; Betageri, R.;
Kirrane, T.; Proudfoot, J. R. Tetrahedron Lett. 2000, 41,
5321–5324; (b) Luo, Y.; Potvin, P. G. J. Org. Chem. 1994,
59, 1761–1765; (c) Finar, I. L.; Hurlock, R. J. J. Chem.
Soc. 1957, 3024–3026; (d) Sugaya, T.; Mimury, Y.; Ikuta,
M.; Mimury, T.; Tomioka, S. Synthesis 1994, 73–76.
9. (a) Singh, S. K.; Saibaba, V.; Rao, K. S.; Rajjak, S. A.;
Casturi, S. R.; Datla, S. R.; Rao, N. V. S. M.; Ramesh,
M.; Ravikanth, B.; Rajagopalan, R.; Venkateswarlu, A.;
Rao, Y. K. Org. Biomol. Chem. 2004, 2, 2442–2450; (b)
unpublished results.
(CDCl3, 400MHz) d 7.19 (d, J = 8.8Hz, 2H), 7.13 (d,
J = 8.8Hz, 2H), 6.83 (d, J = 9.2Hz, 2H), 6.80 (d,
J = 9.2Hz, 2H), 6.23 (s, 1H), 3.80 (s, 3H), 3.79 (s, 3H),
2.67 (t, J = 7.6Hz, 2H), 1.85–1.65 (m, 2H), 1.03 (t,
J = 7.6Hz, 3H). MS (CI Method) 323 [(M+1)+, 100%],
294. HPLC 96.3% (in the presence of TEA) and 98.5%
(without TEA) [Hichrom RPB (250mm), mobile phase
0.01M KH2PO4/CH3CN–CH3OH (50:50), flowrate
1.0mL/min and UV detection at 210nm]. Anal. Calcd
(C20H22N2O2)C: 74.51; found, 74.68; H: calcd, 6.88;
found, 6.72; N: calcd, 8.69; found, 8.53.